Nama's AI scorecard currently rates Universal Health Services Sell (4.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is UHS's P/E ratio?

Universal Health Services trades at a trailing price-to-earnings ratio of 8.6.

When does UHS report earnings?

Universal Health Services's next scheduled report is on Feb 24, 2027. Analysts expect EPS of $5.64.

What is the UHS price target?

The median analyst price target from 17 analysts is $194.00, with a range of $156.00 – $250.00.

Is UHS Shariah compliant?

Nama's AAOIFI-style screen reads Universal Health Services as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does UHS pay a dividend?

Yes — Universal Health Services's dividend yield is 0.4%.

Nama Insights

Universal Health Services (UHS)

Healthcare · Medical Care Facilities · NYSE

S&P 500

Universal Health Services (UHS) is a Healthcare company in the Medical Care Facilities industry. It has a market capitalization of $11.52B, a trailing price-to-earnings ratio of 8.6 and a free-cash-flow yield of 6.5%. Over the most recent reported fiscal year, revenue grew 9.7% and free cash flow per share fell 22.7%. Nama's AI scorecard rates it Sell, 4.2 out of 10. On 12-month momentum it ranks in the trailing band of its market.

AI scorecard

Sell · 4.2/10

Negative, at the mild end of Sell. As of Nov 7, 2026.

Momentum

Trailing · -22.9% over 12 months ex. last

Bottom 20% of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-20.6%

How far the last close sits under the highest price of the past five years.

Market cap	$11.52B
Trailing P/E	8.6
Price / book	1.5
Price / sales	0.6
FCF yield	6.5%
Dividend yield	0.4%
Gross margin	90.7%
Operating margin	11.4%
Net margin	8.4%
Revenue growth (YoY)	+9.7%
Revenue growth (3-yr annual)	+9.0%
EPS growth (YoY)	+30.8%
FCF/share growth (YoY)	-22.7%
Beta	1.0
Exchange	NYSE
Sector	Healthcare
Industry	Medical Care Facilities

UHS earnings

Next report: Feb 24, 2027 (Q4 2026, EPS estimate $5.64). Beat the EPS estimate in 2 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 27, 2026	$5.22	$5.15	+1.4%	—
Q2 2026	Jul 27, 2026	$5.98	$6.01	-0.5%	$4.64B
Q1 2026	Apr 27, 2026	$5.62	$5.46	+2.9%	$4.50B
Q4 2025	Feb 25, 2026	$5.88	$5.91	-0.5%	$4.49B

UHS analyst price target

Median target $194.00 from 17 analysts, ranging $156.00 – $250.00.

Medical Care Facilities peers

Ticker	Company	Market cap	P/E
HCA	HCA Healthcare	$103.40B	16.5
THC	Tenet Healthcare	$22.55B	12.7
EHC	Encompass Health	$13.50B	22.4
FMS	Fresenius Medical Care	$12.15B	10.2
DVA	DaVita	$12.04B	13.6
ENSG	Ensign Group	$10.56B	23.8
PACS	PACS Group	$7.87B	20.1
CHE	Chemed	$6.84B	21.2

Explore live UHS data on Nama Insights →

Recent Congressional trades

Universal Health Services trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Julia Letlow	House	Buy	$1,001 - $15,000	Jan 13, 2026

UHS FAQ

Is UHS a buy?: Nama's AI scorecard currently rates Universal Health Services Sell (4.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is UHS's P/E ratio?: Universal Health Services trades at a trailing price-to-earnings ratio of 8.6.
When does UHS report earnings?: Universal Health Services's next scheduled report is on Feb 24, 2027. Analysts expect EPS of $5.64.
What is the UHS price target?: The median analyst price target from 17 analysts is $194.00, with a range of $156.00 – $250.00.
Is UHS Shariah compliant?: Nama's AAOIFI-style screen reads Universal Health Services as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does UHS pay a dividend?: Yes — Universal Health Services's dividend yield is 0.4%.